Industry Research Reports
Home > Reports > Service & Software > Global Molecular Docking and Virtual Screening Software Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
Global Molecular Docking and Virtual Screening Software Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
Industry: Service & Software
Published Date: 2026-07-16
Pages: 116 Pages
Report ld: 6977012
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Molecular Docking and Virtual Screening Software Market Size(US$)
CAGR 2026-2032
14.8%
Market Size,2032
USD 1,637
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 715 million
Market Forecast in 2032(Value)
US$ 1,637 million
CAGR
14.8%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Molecular Docking and Virtual Screening Software market size was US$ 620 million in 2025 and is forecast to reach a readjusted size of US$ 1637 million by 2032 with a CAGR of 14.8% during the forecast period 2026-2032.
Molecular docking and virtual screening software refers to computer-aided drug design tools used to predict interactions among small molecules, fragments, peptides, or protein complexes. It typically supports receptor preparation, ligand conformation generation, binding-site setup, conformational sampling, scoring, ranking, and visualization to screen large compound libraries for potential hits, with optional capabilities such as pharmacophore screening, shape similarity, induced-fit docking, covalent docking, and MM/GBSA or FEP rescoring. Deployment formats include desktop software, server or HPC clusters, cloud SaaS platforms, and API toolkits, mainly serving new drug discovery, drug repurposing, and lead optimization. The blended gross margin is approximately 75%.
Demand is mainly driven by early-stage innovative drug discovery, AI-enabled drug design platforms, computational chemistry services at CROs, drug repurposing, and academic research. As more protein structures become available, commercial compound libraries expand, and R&D teams seek higher pre-experimental screening efficiency, molecular docking and virtual screening software is moving from an expert-only tool to a standardized platform shared across project teams.
Product upgrades are centered on more complete workflows and higher computational efficiency. Established vendors maintain barriers through physics-based scoring functions, graphical modeling environments, and validated pharmaceutical use cases, while newer entrants emphasize GPU acceleration, cloud elasticity, AI-based pose prediction, automated data pipelines, and API integration. Buyers increasingly evaluate not only docking accuracy, but also protein and ligand preparation, batch job management, rescoring, traceable reporting, data security, and connectivity with ELN, LIMS, ADMET, and FEP platforms.
Regional demand remains concentrated among large pharmaceutical companies, biotech firms, and specialist CROs in North America and Europe, while China, India, and Singapore are growing faster due to the expansion of local AI drug discovery and CXO capabilities. Key risks include wet-lab validation conversion, pricing pressure from open-source tools, customer data security, cloud computing cost, and model generalization; opportunities lie in enterprise private deployment, ultra-large-scale screening, fragment and covalent drug design, DEL or automated synthesis integration, and target-family-specific solutions.
The global Molecular Docking and Virtual Screening Software market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.
MARKET SEGMENTATION
By Company
- Schrödinger
- Dassault Systèmes
- Chemical Computing Group
- OpenEye Cadence Molecular Sciences
- Cambridge Crystallographic Data Centre
- Cresset
- BioSolveIT
- Molsoft
- Molecular Discovery
- DP Technology
- XtalPi
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Structure-Based Docking Software
- Ligand-Based Screening Software
- Pharmacophore Screening Software
- Shape and Electrostatic Similarity Software
- AI-Assisted Docking Software
Segment by Application
- Hit Discovery
- Lead Optimization
- Drug Repurposing
- Fragment-Based Drug Design
- Target Validation and Mechanism Study
- Teaching and Academic Research
Segment by Category
- Desktop Workstation Software
- Server or HPC Software
- Cloud SaaS Platform
- API or Toolkit Software
- Hybrid Deployment Software
Segment by Division
- Small Molecule Docking Software
- Fragment Docking Software
- Peptide Docking Software
- Covalent Ligand Docking Software
- Protein-Protein Docking Software
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Molecular Docking and Virtual Screening Software value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032
1.2.2 Structure-Based Docking Software
1.2.3 Ligand-Based Screening Software
1.2.4 Pharmacophore Screening Software
1.2.5 Shape and Electrostatic Similarity Software
1.2.6 AI-Assisted Docking Software
1.3 Market by Application
1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032
1.3.2 Hit Discovery
1.3.3 Lead Optimization
1.3.4 Drug Repurposing
1.3.5 Fragment-Based Drug Design
1.3.6 Target Validation and Mechanism Study
1.3.7 Teaching and Academic Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Molecular Docking and Virtual Screening Software Market Perspective (2021-2032)
2.2 Global Market Size by Region: 2021 vs 2025 vs 2032
2.3 Global Molecular Docking and Virtual Screening Software Market Share by Revenue, by Region (2021-2026)
2.4 Global Molecular Docking and Virtual Screening Software Revenue Forecast by Region (2027-2032)
2.5 Major Regions and Emerging Markets Analysis
2.5.1 North America Molecular Docking and Virtual Screening Software Market Size and Prospective (2021-2032)
2.5.2 Europe Molecular Docking and Virtual Screening Software Market Size and Prospective (2021-2032)
2.5.3 China Molecular Docking and Virtual Screening Software Market Size and Prospective (2021-2032)
2.5.4 Japan Molecular Docking and Virtual Screening Software Market Size and Prospective (2021-2032)
2.5.5 Southeast Asia Molecular Docking and Virtual Screening Software Market Size and Prospective (2021-2032)
2.5.6 India Molecular Docking and Virtual Screening Software Market Size and Prospective (2021-2032)
2.5.7 South America Molecular Docking and Virtual Screening Software Market Size and Prospective (2021-2032)
2.5.8 Middle East Molecular Docking and Virtual Screening Software Market Size and Prospective (2021-2032)
3 Breakdown Data by Type
3.1 Global Molecular Docking and Virtual Screening Software Historical Market Size by Type (2021-2026)
3.2 Global Molecular Docking and Virtual Screening Software Forecasted Market Size by Type (2027-2032)
3.3 Representative Players for Different Types of Molecular Docking and Virtual Screening Software
4 Breakdown Data by Application
4.1 Global Molecular Docking and Virtual Screening Software Historical Market Size by Application (2021-2026)
4.2 Global Molecular Docking and Virtual Screening Software Forecasted Market Size by Application (2027-2032)
4.3 New Sources of Growth in Molecular Docking and Virtual Screening Software Applications
5 Competitive Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Molecular Docking and Virtual Screening Software Players by Revenue (2021-2026)
5.1.2 Global Molecular Docking and Virtual Screening Software Market Share by Revenue, by Players (2021-2026)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Molecular Docking and Virtual Screening Software Revenue
5.4 Global Molecular Docking and Virtual Screening Software Market Concentration Analysis
5.4.1 Global Molecular Docking and Virtual Screening Software Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Molecular Docking and Virtual Screening Software Revenue in 2025
5.5 Global Key Players of Molecular Docking and Virtual Screening Software Head Offices and Areas Served
5.6 Global Key Players of Molecular Docking and Virtual Screening Software, Product and Application
5.7 Global Key Players of Molecular Docking and Virtual Screening Software, Date of Entry into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Molecular Docking and Virtual Screening Software Revenue by Company (2021-2026)
6.1.2 North America Market Size by Type
6.1.2.1 North America Molecular Docking and Virtual Screening Software Market Size by Type (2021-2026)
6.1.2.2 North America Molecular Docking and Virtual Screening Software Market Share by Type (2021-2026)
6.1.3 North America Market Size by Application
6.1.3.1 North America Molecular Docking and Virtual Screening Software Market Size by Application (2021-2026)
6.1.3.2 North America Molecular Docking and Virtual Screening Software Market Share by Application (2021-2026)
6.1.4 North America Molecular Docking and Virtual Screening Software Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Molecular Docking and Virtual Screening Software Revenue by Company (2021-2026)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Molecular Docking and Virtual Screening Software Market Size by Type (2021-2026)
6.2.2.2 Europe Molecular Docking and Virtual Screening Software Market Share by Type (2021-2026)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Molecular Docking and Virtual Screening Software Market Size by Application (2021-2026)
6.2.3.2 Europe Molecular Docking and Virtual Screening Software Market Share by Application (2021-2026)
6.2.4 Europe Molecular Docking and Virtual Screening Software Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Molecular Docking and Virtual Screening Software Revenue by Company (2021-2026)
6.3.2 China Market Size by Type
6.3.2.1 China Molecular Docking and Virtual Screening Software Market Size by Type (2021-2026)
6.3.2.2 China Molecular Docking and Virtual Screening Software Market Share by Type (2021-2026)
6.3.3 China Market Size by Application
6.3.3.1 China Molecular Docking and Virtual Screening Software Market Size by Application (2021-2026)
6.3.3.2 China Molecular Docking and Virtual Screening Software Market Share by Application (2021-2026)
6.3.4 China Molecular Docking and Virtual Screening Software Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Molecular Docking and Virtual Screening Software Revenue by Company (2021-2026)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Molecular Docking and Virtual Screening Software Market Size by Type (2021-2026)
6.4.2.2 Japan Molecular Docking and Virtual Screening Software Market Share by Type (2021-2026)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Molecular Docking and Virtual Screening Software Market Size by Application (2021-2026)
6.4.3.2 Japan Molecular Docking and Virtual Screening Software Market Share by Application (2021-2026)
6.4.4 Japan Molecular Docking and Virtual Screening Software Major Customers
6.4.5 Japan Market Trends and Opportunities
6.5 Southeast Asia Market: Players, Segments, Downstream and Major Customers
6.5.1 Southeast Asia Molecular Docking and Virtual Screening Software Revenue by Company (2021-2026)
6.5.2 Southeast Asia Market Size by Type
6.5.2.1 Southeast Asia Molecular Docking and Virtual Screening Software Market Size by Type (2021-2026)
6.5.2.2 Southeast Asia Molecular Docking and Virtual Screening Software Market Share by Type (2021-2026)
6.5.3 Southeast Asia Market Size by Application
6.5.3.1 Southeast Asia Molecular Docking and Virtual Screening Software Market Size by Application (2021-2026)
6.5.3.2 Southeast Asia Molecular Docking and Virtual Screening Software Market Share by Application (2021-2026)
6.5.4 Southeast Asia Molecular Docking and Virtual Screening Software Major Customers
6.5.5 Southeast Asia Market Trends and Opportunities
6.6 India Market: Players, Segments, Downstream and Major Customers
6.6.1 India Molecular Docking and Virtual Screening Software Revenue by Company (2021-2026)
6.6.2 India Market Size by Type
6.6.2.1 India Molecular Docking and Virtual Screening Software Market Size by Type (2021-2026)
6.6.2.2 India Molecular Docking and Virtual Screening Software Market Share by Type (2021-2026)
6.6.3 India Market Size by Application
6.6.3.1 India Molecular Docking and Virtual Screening Software Market Size by Application (2021-2026)
6.6.3.2 India Molecular Docking and Virtual Screening Software Market Share by Application (2021-2026)
6.6.4 India Molecular Docking and Virtual Screening Software Major Customers
6.6.5 India Market Trends and Opportunities
7 Key Player Profiles
7.1 Schrödinger
7.1.1 Schrödinger Company Details
7.1.2 Schrödinger Business Overview
7.1.3 Schrödinger Molecular Docking and Virtual Screening Software Introduction
7.1.4 Schrödinger Revenue in Molecular Docking and Virtual Screening Software Business (2021-2026)
7.1.5 Schrödinger Recent Development
7.2 Dassault Systèmes
7.2.1 Dassault Systèmes Company Details
7.2.2 Dassault Systèmes Business Overview
7.2.3 Dassault Systèmes Molecular Docking and Virtual Screening Software Introduction
7.2.4 Dassault Systèmes Revenue in Molecular Docking and Virtual Screening Software Business (2021-2026)
7.2.5 Dassault Systèmes Recent Development
7.3 Chemical Computing Group
7.3.1 Chemical Computing Group Company Details
7.3.2 Chemical Computing Group Business Overview
7.3.3 Chemical Computing Group Molecular Docking and Virtual Screening Software Introduction
7.3.4 Chemical Computing Group Revenue in Molecular Docking and Virtual Screening Software Business (2021-2026)
7.3.5 Chemical Computing Group Recent Development
7.4 OpenEye Cadence Molecular Sciences
7.4.1 OpenEye Cadence Molecular Sciences Company Details
7.4.2 OpenEye Cadence Molecular Sciences Business Overview
7.4.3 OpenEye Cadence Molecular Sciences Molecular Docking and Virtual Screening Software Introduction
7.4.4 OpenEye Cadence Molecular Sciences Revenue in Molecular Docking and Virtual Screening Software Business (2021-2026)
7.4.5 OpenEye Cadence Molecular Sciences Recent Development
7.5 Cambridge Crystallographic Data Centre
7.5.1 Cambridge Crystallographic Data Centre Company Details
7.5.2 Cambridge Crystallographic Data Centre Business Overview
7.5.3 Cambridge Crystallographic Data Centre Molecular Docking and Virtual Screening Software Introduction
7.5.4 Cambridge Crystallographic Data Centre Revenue in Molecular Docking and Virtual Screening Software Business (2021-2026)
7.5.5 Cambridge Crystallographic Data Centre Recent Development
7.6 Cresset
7.6.1 Cresset Company Details
7.6.2 Cresset Business Overview
7.6.3 Cresset Molecular Docking and Virtual Screening Software Introduction
7.6.4 Cresset Revenue in Molecular Docking and Virtual Screening Software Business (2021-2026)
7.6.5 Cresset Recent Development
7.7 BioSolveIT
7.7.1 BioSolveIT Company Details
7.7.2 BioSolveIT Business Overview
7.7.3 BioSolveIT Molecular Docking and Virtual Screening Software Introduction
7.7.4 BioSolveIT Revenue in Molecular Docking and Virtual Screening Software Business (2021-2026)
7.7.5 BioSolveIT Recent Development
7.8 Molsoft
7.8.1 Molsoft Company Details
7.8.2 Molsoft Business Overview
7.8.3 Molsoft Molecular Docking and Virtual Screening Software Introduction
7.8.4 Molsoft Revenue in Molecular Docking and Virtual Screening Software Business (2021-2026)
7.8.5 Molsoft Recent Development
7.9 Molecular Discovery
7.9.1 Molecular Discovery Company Details
7.9.2 Molecular Discovery Business Overview
7.9.3 Molecular Discovery Molecular Docking and Virtual Screening Software Introduction
7.9.4 Molecular Discovery Revenue in Molecular Docking and Virtual Screening Software Business (2021-2026)
7.9.5 Molecular Discovery Recent Development
7.10 DP Technology
7.10.1 DP Technology Company Details
7.10.2 DP Technology Business Overview
7.10.3 DP Technology Molecular Docking and Virtual Screening Software Introduction
7.10.4 DP Technology Revenue in Molecular Docking and Virtual Screening Software Business (2021-2026)
7.10.5 DP Technology Recent Development
7.11 XtalPi
7.11.1 XtalPi Company Details
7.11.2 XtalPi Business Overview
7.11.3 XtalPi Molecular Docking and Virtual Screening Software Introduction
7.11.4 XtalPi Revenue in Molecular Docking and Virtual Screening Software Business (2021-2026)
7.11.5 XtalPi Recent Development
8 Molecular Docking and Virtual Screening Software Market Dynamics
8.1 Molecular Docking and Virtual Screening Software Industry Trends
8.2 Molecular Docking and Virtual Screening Software Market Drivers
8.3 Molecular Docking and Virtual Screening Software Market Challenges
8.4 Molecular Docking and Virtual Screening Software Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Molecular Docking and Virtual Screening Software Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Global Molecular Docking and Virtual Screening Software Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 3. Global Market Molecular Docking and Virtual Screening Software Market Size (US$ Million) by Region:2021 vs 2025 vs 2032
Table 4. Global Molecular Docking and Virtual Screening Software Revenue (US$ Million) Market Share by Region (2021-2026)
Table 5. Global Molecular Docking and Virtual Screening Software Revenue Share by Region (2021-2026)
Table 6. Global Molecular Docking and Virtual Screening Software Revenue (US$ Million) Forecast by Region (2027-2032)
Table 7. Global Molecular Docking and Virtual Screening Software Revenue Share Forecast by Region (2027-2032)
Table 8. Global Molecular Docking and Virtual Screening Software Market Size by Type (2021-2026) & (US$ Million)
Table 9. Global Molecular Docking and Virtual Screening Software Market Share by Revenue, by Type (2021-2026)
Table 10. Global Molecular Docking and Virtual Screening Software Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 11. Global Molecular Docking and Virtual Screening Software Market Share by Revenue, by Type (2027-2032)
Table 12. Representative Players of Each Type
Table 13. Global Molecular Docking and Virtual Screening Software Market Size by Application (2021-2026) & (US$ Million)
Table 14. Global Molecular Docking and Virtual Screening Software Market Share by Revenue, by Application (2021-2026)
Table 15. Global Molecular Docking and Virtual Screening Software Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 16. Global Molecular Docking and Virtual Screening Software Market Share by Revenue, by Application (2027-2032)
Table 17. New Sources of Growth in Molecular Docking and Virtual Screening Software Applications
Table 18. Global Molecular Docking and Virtual Screening Software Revenue by Players (2021-2026) & (US$ Million)
Table 19. Global Molecular Docking and Virtual Screening Software Market Share by Players (2021-2026)
Table 20. Global Top Molecular Docking and Virtual Screening Software Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Docking and Virtual Screening Software as of 2025)
Table 21. Ranking of Global Top Molecular Docking and Virtual Screening Software Companies by Revenue (US$ Million) in 2025
Table 22. Global 5 Largest Players Market Share by Molecular Docking and Virtual Screening Software Revenue (CR5 and HHI) & (2021-2026)
Table 23. Global Key Players of Molecular Docking and Virtual Screening Software, Headquarters and Area Served
Table 24. Global Key Players of Molecular Docking and Virtual Screening Software, Product and Application
Table 25. Global Key Players of Molecular Docking and Virtual Screening Software, Date of Entry into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Molecular Docking and Virtual Screening Software Revenue by Company (2021-2026) & (US$ Million)
Table 28. North America Molecular Docking and Virtual Screening Software Market Share by Revenue, by Company (2021-2026)
Table 29. North America Molecular Docking and Virtual Screening Software Market Size by Type (2021-2026) & (US$ Million)
Table 30. North America Molecular Docking and Virtual Screening Software Market Size by Application (2021-2026) & (US$ Million)
Table 31. Europe Molecular Docking and Virtual Screening Software Revenue by Company (2021-2026) & (US$ Million)
Table 32. Europe Molecular Docking and Virtual Screening Software Market Share by Revenue, by Company (2021-2026)
Table 33. Europe Molecular Docking and Virtual Screening Software Market Size by Type (2021-2026) & (US$ Million)
Table 34. Europe Molecular Docking and Virtual Screening Software Market Size by Application (2021-2026) & (US$ Million)
Table 35. China Molecular Docking and Virtual Screening Software Revenue by Company (2021-2026) & (US$ Million)
Table 36. China Molecular Docking and Virtual Screening Software Market Share by Revenue, by Company (2021-2026)
Table 37. China Molecular Docking and Virtual Screening Software Market Size by Type (2021-2026) & (US$ Million)
Table 38. China Molecular Docking and Virtual Screening Software Market Size by Application (2021-2026) & (US$ Million)
Table 39. Japan Molecular Docking and Virtual Screening Software Revenue by Company (2021-2026) & (US$ Million)
Table 40. Japan Molecular Docking and Virtual Screening Software Market Share by Revenue, by Company (2021-2026)
Table 41. Japan Molecular Docking and Virtual Screening Software Market Size by Type (2021-2026) & (US$ Million)
Table 42. Japan Molecular Docking and Virtual Screening Software Market Size by Application (2021-2026) & (US$ Million)
Table 43. Southeast Asia Molecular Docking and Virtual Screening Software Revenue by Company (2021-2026) & (US$ Million)
Table 44. Southeast Asia Molecular Docking and Virtual Screening Software Market Share by Revenue, by Company (2021-2026)
Table 45. Southeast Asia Molecular Docking and Virtual Screening Software Market Size by Type (2021-2026) & (US$ Million)
Table 46. Southeast Asia Molecular Docking and Virtual Screening Software Market Size by Application (2021-2026) & (US$ Million)
Table 47. India Molecular Docking and Virtual Screening Software Revenue by Company (2021-2026) & (US$ Million)
Table 48. India Molecular Docking and Virtual Screening Software Market Share by Revenue, by Company (2021-2026)
Table 49. India Molecular Docking and Virtual Screening Software Market Size by Type (2021-2026) & (US$ Million)
Table 50. India Molecular Docking and Virtual Screening Software Market Size by Application (2021-2026) & (US$ Million)
Table 51. Schrödinger Company Details
Table 52. Schrödinger Business Overview
Table 53. Schrödinger Molecular Docking and Virtual Screening Software Product
Table 54. Schrödinger Revenue in Molecular Docking and Virtual Screening Software Business (2021-2026) & (US$ Million)
Table 55. Schrödinger Recent Development
Table 56. Dassault Systèmes Company Details
Table 57. Dassault Systèmes Business Overview
Table 58. Dassault Systèmes Molecular Docking and Virtual Screening Software Product
Table 59. Dassault Systèmes Revenue in Molecular Docking and Virtual Screening Software Business (2021-2026) & (US$ Million)
Table 60. Dassault Systèmes Recent Development
Table 61. Chemical Computing Group Company Details
Table 62. Chemical Computing Group Business Overview
Table 63. Chemical Computing Group Molecular Docking and Virtual Screening Software Product
Table 64. Chemical Computing Group Revenue in Molecular Docking and Virtual Screening Software Business (2021-2026) & (US$ Million)
Table 65. Chemical Computing Group Recent Development
Table 66. OpenEye Cadence Molecular Sciences Company Details
Table 67. OpenEye Cadence Molecular Sciences Business Overview
Table 68. OpenEye Cadence Molecular Sciences Molecular Docking and Virtual Screening Software Product
Table 69. OpenEye Cadence Molecular Sciences Revenue in Molecular Docking and Virtual Screening Software Business (2021-2026) & (US$ Million)
Table 70. OpenEye Cadence Molecular Sciences Recent Development
Table 71. Cambridge Crystallographic Data Centre Company Details
Table 72. Cambridge Crystallographic Data Centre Business Overview
Table 73. Cambridge Crystallographic Data Centre Molecular Docking and Virtual Screening Software Product
Table 74. Cambridge Crystallographic Data Centre Revenue in Molecular Docking and Virtual Screening Software Business (2021-2026) & (US$ Million)
Table 75. Cambridge Crystallographic Data Centre Recent Development
Table 76. Cresset Company Details
Table 77. Cresset Business Overview
Table 78. Cresset Molecular Docking and Virtual Screening Software Product
Table 79. Cresset Revenue in Molecular Docking and Virtual Screening Software Business (2021-2026) & (US$ Million)
Table 80. Cresset Recent Development
Table 81. BioSolveIT Company Details
Table 82. BioSolveIT Business Overview
Table 83. BioSolveIT Molecular Docking and Virtual Screening Software Product
Table 84. BioSolveIT Revenue in Molecular Docking and Virtual Screening Software Business (2021-2026) & (US$ Million)
Table 85. BioSolveIT Recent Development
Table 86. Molsoft Company Details
Table 87. Molsoft Business Overview
Table 88. Molsoft Molecular Docking and Virtual Screening Software Product
Table 89. Molsoft Revenue in Molecular Docking and Virtual Screening Software Business (2021-2026) & (US$ Million)
Table 90. Molsoft Recent Development
Table 91. Molecular Discovery Company Details
Table 92. Molecular Discovery Business Overview
Table 93. Molecular Discovery Molecular Docking and Virtual Screening Software Product
Table 94. Molecular Discovery Revenue in Molecular Docking and Virtual Screening Software Business (2021-2026) & (US$ Million)
Table 95. Molecular Discovery Recent Development
Table 96. DP Technology Company Details
Table 97. DP Technology Business Overview
Table 98. DP Technology Molecular Docking and Virtual Screening Software Product
Table 99. DP Technology Revenue in Molecular Docking and Virtual Screening Software Business (2021-2026) & (US$ Million)
Table 100. DP Technology Recent Development
Table 101. XtalPi Company Details
Table 102. XtalPi Business Overview
Table 103. XtalPi Molecular Docking and Virtual Screening Software Product
Table 104. XtalPi Revenue in Molecular Docking and Virtual Screening Software Business (2021-2026) & (US$ Million)
Table 105. XtalPi Recent Development
Table 106. Molecular Docking and Virtual Screening Software Market Trends
Table 107. Molecular Docking and Virtual Screening Software Market Drivers
Table 108. Molecular Docking and Virtual Screening Software Market Challenges
Table 109. Molecular Docking and Virtual Screening Software Market Restraints
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Molecular Docking and Virtual Screening Software Product Picture
Figure 2. Global Molecular Docking and Virtual Screening Software Market Share by Type: 2025 vs 2032
Figure 3. Structure-Based Docking Software Features
Figure 4. Ligand-Based Screening Software Features
Figure 5. Pharmacophore Screening Software Features
Figure 6. Shape and Electrostatic Similarity Software Features
Figure 7. AI-Assisted Docking Software Features
Figure 8. Global Molecular Docking and Virtual Screening Software Market Share by Application: 2025 vs 2032
Figure 9. Hit Discovery
Figure 10. Lead Optimization
Figure 11. Drug Repurposing
Figure 12. Fragment-Based Drug Design
Figure 13. Target Validation and Mechanism Study
Figure 14. Teaching and Academic Research
Figure 15. Molecular Docking and Virtual Screening Software Report Years Considered
Figure 16. Global Molecular Docking and Virtual Screening Software Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 17. Global Molecular Docking and Virtual Screening Software Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 18. Global Molecular Docking and Virtual Screening Software Market Share by Revenue, by Region: 2021 vs 2025
Figure 19. North America Molecular Docking and Virtual Screening Software Revenue (US$ Million) Growth Rate (2021-2032)
Figure 20. Europe Molecular Docking and Virtual Screening Software Revenue (US$ Million) Growth Rate (2021-2032)
Figure 21. China Molecular Docking and Virtual Screening Software Revenue (US$ Million) Growth Rate (2021-2032)
Figure 22. Japan Molecular Docking and Virtual Screening Software Revenue (US$ Million) Growth Rate (2021-2032)
Figure 23. Southeast Asia Molecular Docking and Virtual Screening Software Revenue (US$ Million) Growth Rate (2021-2032)
Figure 24. India Molecular Docking and Virtual Screening Software Revenue (US$ Million) Growth Rate (2021-2032)
Figure 25. South America Molecular Docking and Virtual Screening Software Revenue (US$ Million) Growth Rate (2021-2032)
Figure 26. Middle East Molecular Docking and Virtual Screening Software Revenue (US$ Million) Growth Rate (2021-2032)
Figure 27. Global Molecular Docking and Virtual Screening Software Market Share by Players in 2025
Figure 28. Global Top Molecular Docking and Virtual Screening Software Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Docking and Virtual Screening Software as of 2025)
Figure 29. The Top 10 and 5 Players Market Share by Molecular Docking and Virtual Screening Software Revenue in 2025
Figure 30. North America Molecular Docking and Virtual Screening Software Market Share by Type (2021-2026)
Figure 31. North America Molecular Docking and Virtual Screening Software Market Share by Application (2021-2026)
Figure 32. Europe Molecular Docking and Virtual Screening Software Market Share by Type (2021-2026)
Figure 33. Europe Molecular Docking and Virtual Screening Software Market Share by Application (2021-2026)
Figure 34. China Molecular Docking and Virtual Screening Software Market Share by Type (2021-2026)
Figure 35. China Molecular Docking and Virtual Screening Software Market Share by Application (2021-2026)
Figure 36. Japan Molecular Docking and Virtual Screening Software Market Share by Type (2021-2026)
Figure 37. Japan Molecular Docking and Virtual Screening Software Market Share by Application (2021-2026)
Figure 38. Southeast Asia Molecular Docking and Virtual Screening Software Market Share by Type (2021-2026)
Figure 39. Southeast Asia Molecular Docking and Virtual Screening Software Market Share by Application (2021-2026)
Figure 40. India Molecular Docking and Virtual Screening Software Market Share by Type (2021-2026)
Figure 41. India Molecular Docking and Virtual Screening Software Market Share by Application (2021-2026)
Figure 42. Schrödinger Revenue Growth Rate in Molecular Docking and Virtual Screening Software Business (2021-2026)
Figure 43. Dassault Systèmes Revenue Growth Rate in Molecular Docking and Virtual Screening Software Business (2021-2026)
Figure 44. Chemical Computing Group Revenue Growth Rate in Molecular Docking and Virtual Screening Software Business (2021-2026)
Figure 45. OpenEye Cadence Molecular Sciences Revenue Growth Rate in Molecular Docking and Virtual Screening Software Business (2021-2026)
Figure 46. Cambridge Crystallographic Data Centre Revenue Growth Rate in Molecular Docking and Virtual Screening Software Business (2021-2026)
Figure 47. Cresset Revenue Growth Rate in Molecular Docking and Virtual Screening Software Business (2021-2026)
Figure 48. BioSolveIT Revenue Growth Rate in Molecular Docking and Virtual Screening Software Business (2021-2026)
Figure 49. Molsoft Revenue Growth Rate in Molecular Docking and Virtual Screening Software Business (2021-2026)
Figure 50. Molecular Discovery Revenue Growth Rate in Molecular Docking and Virtual Screening Software Business (2021-2026)
Figure 51. DP Technology Revenue Growth Rate in Molecular Docking and Virtual Screening Software Business (2021-2026)
Figure 52. XtalPi Revenue Growth Rate in Molecular Docking and Virtual Screening Software Business (2021-2026)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Molecular Docking and Virtual Screening Software in 2026?
The global market size of Molecular Docking and Virtual Screening Software in 2026 was 715 Million USD.
What was the global market size of Molecular Docking and Virtual Screening Software in 2032?
Which region is expected to have the highest market share?
Which companies rank high in the global Molecular Docking and Virtual Screening Software market?
What is the annual compound growth rate of the global Molecular Docking and Virtual Screening Software market size from 2026 to 2032?
Related Reports
Global Molecular Docking and Virtual Screening Software Market Research Report 2026
The global Molecular Docking and Virtual Screening Software market was valued at US$ 620 million in 2025 and is anticipated to reach US$ 1637 million by 2032, at a CAGR of 14.8% from 2026 to 2032.
Published Date: 2026-07-16
Pages: 115
USD 2900.00
(Single User License)
Molecular Docking and Virtual Screening Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Molecular Docking and Virtual Screening Software was estimated to be worth US$ 620 million in 2025 and is projected to reach US$ 1637 million, growing at a CAGR of 14.8% from 2026 to 2032.
Published Date: 2026-07-16
Pages: 115
USD 3950.00
(Single User License)
Global Molecular Docking and Virtual Screening Software Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Molecular Docking and Virtual Screening Software market is projected to grow from US$ 620 million in 2025 to US$ 1637 million by 2032, at a CAGR of 14.8% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-07-16
Pages: 142
USD 4900.00
(Single User License)
Global Molecular Docking and Virtual Screening Software Market Research Report 2026
The global Molecular Docking and Virtual Screening Software market was valued at US$ 620 million in 2025 and is anticipated to reach US$ 1637 million by 2032, at a CAGR of 14.8% from 2026 to 2032.
Published: 2026-07-16
Pages: 115
USD 2900.00 (Single User License)Molecular Docking and Virtual Screening Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Molecular Docking and Virtual Screening Software was estimated to be worth US$ 620 million in 2025 and is projected to reach US$ 1637 million, growing at a CAGR of 14.8% from 2026 to 2032.
Published: 2026-07-16
Pages: 115
USD 3950.00 (Single User License)Global Molecular Docking and Virtual Screening Software Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Molecular Docking and Virtual Screening Software market is projected to grow from US$ 620 million in 2025 to US$ 1637 million by 2032, at a CAGR of 14.8% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-07-16
Pages: 142
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4250.00
USD 6375.00
USD 8500.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now